Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Repeatability of arterial input functions and kinetic parameters in muscle obtained by dynamic contrast enhanced MR imaging of the head and neck.

Koopman T, Martens RM, Lavini C, Yaqub M, Castelijns JA, Boellaard R, Marcus JT.

Magn Reson Imaging. 2020 Jan 21;68:1-8. doi: 10.1016/j.mri.2020.01.010. [Epub ahead of print]

2.

Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

Braams NJ, Ruigrok D, Schokker MGM, Padervinskiene L, de Man FS, Marcus JT, Lely RJ, Beijk MAM, Klok FA, Huisman MV, Nossent EJ, Vonk Noordegraaf A, Symersky P, Bogaard HJ, Meijboom LJ.

J Heart Lung Transplant. 2020 Mar;39(3):248-256. doi: 10.1016/j.healun.2019.11.020. Epub 2019 Dec 5.

PMID:
31866175
3.

Hemodynamic Effects of Pulmonary Arterial Hypertension-Specific Therapy in Patients With Heart Failure With Preserved Ejection Fraction and With Combined Post- and Precapillay Pulmonary Hypertension.

Huis In't Veld AE, Oosterveer FPT, De Man FS, Marcus JT, Nossent EJ, Boonstra A, Van Rossum ACB, Vonk Noordegraaf A, Bogaard HJ, Handoko ML.

J Card Fail. 2020 Jan;26(1):26-34. doi: 10.1016/j.cardfail.2019.07.547. Epub 2019 Aug 5.

PMID:
31394199
4.

Vena cava backflow and right ventricular stiffness in pulmonary arterial hypertension.

Marcus JT, Westerhof BE, Groeneveldt JA, Bogaard HJ, de Man FS, Vonk Noordegraaf A.

Eur Respir J. 2019 Oct 17;54(4). pii: 1900625. doi: 10.1183/13993003.00625-2019. Print 2019 Oct.

PMID:
31320456
5.

Right Ventricular Load and Function in Chronic Thromboembolic Pulmonary Hypertension: Differences between Proximal and Distal Chronic Thromboembolic Pulmonary Hypertension.

Ruigrok D, Meijboom LJ, Westerhof BE, In 't Veld AH, van der Bruggen CEE, Marcus JT, Nossent EJ, Vonk Noordegraaf A, Symersky P, Bogaard HJ.

Am J Respir Crit Care Med. 2019 May 1;199(9):1163-1166. doi: 10.1164/rccm.201808-1562LE. No abstract available.

PMID:
30768356
6.

EXPRESS: Preserving right ventricular function in patients with pulmonary arterial hypertension: single centre experience with a cardiac magnetic resonance imaging-guided treatment strategy.

Huis In 't Veld AE, Van de Veerdonk MC, Spruijt O, Groeneveldt JA, Marcus JT, Westerhof N, Bogaard HJ, Vonk-Noordegraaf A.

Pulm Circ. 2019 Jan 11:2045894018824553. doi: 10.1177/2045894018824553. [Epub ahead of print] No abstract available.

PMID:
30632454
7.

Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.

Martens RM, Noij DP, Ali M, Koopman T, Marcus JT, Vergeer MR, de Vet H, de Jong MC, Leemans CR, Hoekstra OS, de Bree R, de Graaf P, Boellaard R, Castelijns JA.

Oral Oncol. 2019 Jan;88:75-83. doi: 10.1016/j.oraloncology.2018.11.005. Epub 2018 Nov 22. Review.

8.

Estimating the arterial input function from dynamic contrast-enhanced MRI data with compensation for flow enhancement (II): Applications in spine diagnostics and assessment of crohn's disease.

van Schie JJN, Lavini C, van Vliet LJ, Kramer G, Pieters-van den Bos I, Marcus JT, Stoker J, Vos FM.

J Magn Reson Imaging. 2018 May;47(5):1197-1204. doi: 10.1002/jmri.25905. Epub 2017 Nov 28.

PMID:
29193469
9.

MRI protocol optimization for quantitative DCE-MRI of the spine.

Lavini C, Kramer G, Pieters-den Bos I, Hoekstra O, Marcus JT.

Magn Reson Imaging. 2017 Dec;44:96-103. doi: 10.1016/j.mri.2017.08.010. Epub 2017 Sep 1.

PMID:
28867668
10.

Treatment response in patients with idiopathic pulmonary arterial hypertension and a severely reduced diffusion capacity.

van der Bruggen CE, Spruijt OA, Nossent EJ, Trip P, Marcus JT, de Man FS, Jan Bogaard H, Noordegraaf AV.

Pulm Circ. 2017 Mar 13;7(1):137-144. doi: 10.1086/690016. eCollection 2017 Mar.

11.

Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension.

van de Veerdonk MC, Huis In T Veld AE, Marcus JT, Westerhof N, Heymans MW, Bogaard HJ, Vonk-Noordegraaf A.

Eur Respir J. 2017 Jun 29;49(6). pii: 1700007. doi: 10.1183/13993003.00007-2017. Print 2017 Jun.

12.

Intravoxel incoherent motion magnetic resonance imaging in head and neck cancer: A systematic review of the diagnostic and prognostic value.

Noij DP, Martens RM, Marcus JT, de Bree R, Leemans CR, Castelijns JA, de Jong MC, de Graaf P.

Oral Oncol. 2017 May;68:81-91. doi: 10.1016/j.oraloncology.2017.03.016. Epub 2017 Apr 2. Review.

13.

CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension.

Huis In 't Veld AE, Van Vliet AG, Spruijt OA, Handoko ML, Marcus JT, Vonk Noordegraaf A, Bogaard HJ.

Int J Cardiol. 2016 Nov 15;223:723-728. doi: 10.1016/j.ijcard.2016.08.314. Epub 2016 Aug 22.

PMID:
27573596
14.

Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study.

van Campen JS, de Boer K, van de Veerdonk MC, van der Bruggen CE, Allaart CP, Raijmakers PG, Heymans MW, Marcus JT, Harms HJ, Handoko ML, de Man FS, Vonk Noordegraaf A, Bogaard HJ.

Eur Respir J. 2016 Sep;48(3):787-96. doi: 10.1183/13993003.00090-2016. Epub 2016 Jul 7.

15.

Serial assessment of right ventricular systolic function in patients with precapillary pulmonary hypertension using simple echocardiographic parameters: A comparison with cardiac magnetic resonance imaging.

Spruijt OA, Di Pasqua MC, Bogaard HJ, van der Bruggen CE, Oosterveer F, Marcus JT, Vonk-Noordegraaf A, Handoko ML.

J Cardiol. 2017 Jan;69(1):182-188. doi: 10.1016/j.jjcc.2016.02.019. Epub 2016 Mar 22.

16.

Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.

van der Bruggen CE, Happé CM, Dorfmüller P, Trip P, Spruijt OA, Rol N, Hoevenaars FP, Houweling AC, Girerd B, Marcus JT, Mercier O, Humbert M, Handoko ML, van der Velden J, Vonk Noordegraaf A, Bogaard HJ, Goumans MJ, de Man FS.

Circulation. 2016 May 3;133(18):1747-60. doi: 10.1161/CIRCULATIONAHA.115.020696. Epub 2016 Mar 16.

PMID:
26984938
17.

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib.

van den Boogaart VE, de Lussanet QG, Houben RM, de Ruysscher D, Groen HJ, Marcus JT, Smit EF, Dingemans AM, Backes WH.

Lung Cancer. 2016 Mar;93:20-7. doi: 10.1016/j.lungcan.2015.12.009. Epub 2015 Dec 30.

PMID:
26898610
18.

Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertension.

Spruijt OA, Vissers L, Bogaard HJ, Hofman MB, Vonk-Noordegraaf A, Marcus JT.

Int J Cardiovasc Imaging. 2016 Mar;32(3):451-9. doi: 10.1007/s10554-015-0787-7. Epub 2015 Oct 16.

19.

Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension.

Trip P, Rain S, Handoko ML, van der Bruggen C, Bogaard HJ, Marcus JT, Boonstra A, Westerhof N, Vonk-Noordegraaf A, de Man FS.

Eur Respir J. 2015 Jun;45(6):1603-12. doi: 10.1183/09031936.00156714. Epub 2015 Apr 16.

20.

Contrast-enhanced perfusion magnetic resonance imaging for head and neck squamous cell carcinoma: a systematic review.

Noij DP, de Jong MC, Mulders LG, Marcus JT, de Bree R, Lavini C, de Graaf P, Castelijns JA.

Oral Oncol. 2015 Feb;51(2):124-38. doi: 10.1016/j.oraloncology.2014.10.016. Epub 2014 Nov 20. Review.

PMID:
25467775
21.

Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension.

van de Veerdonk MC, Marcus JT, Westerhof N, de Man FS, Boonstra A, Heymans MW, Bogaard HJ, Vonk Noordegraaf A.

Chest. 2015 Apr;147(4):1063-1071. doi: 10.1378/chest.14-0701.

PMID:
25376008
22.

State of the art: advanced imaging of the right ventricle and pulmonary circulation in humans (2013 Grover Conference series).

van de Veerdonk MC, Marcus JT, Bogaard HJ, Vonk Noordegraaf A.

Pulm Circ. 2014 Jun;4(2):158-68. doi: 10.1086/675978. Review.

23.

Effect of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension on stroke volume response to exercise.

Surie S, van der Plas MN, Marcus JT, Kind T, Kloek JJ, Vonk-Noordegraaf A, Bresser P.

Am J Cardiol. 2014 Jul 1;114(1):136-40. doi: 10.1016/j.amjcard.2014.04.016. Epub 2014 Apr 18.

PMID:
24819907
24.

The interventricular septum in pulmonary hypertension does not show features of right ventricular failure.

Ruiter G, van de Veerdonk MC, Bogaard HJ, Wong YY, Marcus JT, Lammertsma AA, Westerhof N, van der Laarse WJ, de Man FS, Vonk-Noordegraaf A.

Int J Cardiol. 2014 May 15;173(3):509-12. doi: 10.1016/j.ijcard.2014.03.064. Epub 2014 Mar 18. No abstract available.

PMID:
24684998
25.

The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension.

Jacobs W, van de Veerdonk MC, Trip P, de Man F, Heymans MW, Marcus JT, Kawut SM, Bogaard HJ, Boonstra A, Vonk Noordegraaf A.

Chest. 2014 Jun;145(6):1230-1236. doi: 10.1378/chest.13-1291.

26.

The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload.

van de Veerdonk MC, Dusoswa SA, Marcus JT, Bogaard HJ, Spruijt O, Kind T, Westerhof N, Vonk-Noordegraaf A.

Int J Cardiovasc Imaging. 2014 Feb;30(2):357-65. doi: 10.1007/s10554-013-0338-z. Epub 2013 Dec 4.

PMID:
24306052
27.

Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study.

Peacock AJ, Crawley S, McLure L, Blyth KG, Vizza CD, Poscia R, Francone M, Iacucci I, Olschewski H, Kovacs G, Vonk Noordegraaf A, Marcus JT, van de Veerdonk MC, Oosterveer FP.

Circ Cardiovasc Imaging. 2014 Jan;7(1):107-14. doi: 10.1161/CIRCIMAGING.113.000629. Epub 2013 Oct 30. Erratum in: Circ Cardiovasc Imaging. 2017 Feb;10 (2):.

PMID:
24173272
28.

ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study).

Güçlü A, Germans T, Witjas-Paalberends ER, Stienen GJ, Brouwer WP, Harms HJ, Marcus JT, Vonk AB, Stooker W, Yilmaz A, Klein P, Ten Berg JM, Kluin J, Asselbergs FW, Lammertsma AA, Knaapen P, van Rossum AC, van der Velden J.

Neth Heart J. 2013 Dec;21(12):567-71. doi: 10.1007/s12471-013-0478-8.

29.

Right ventricular diastolic impairment in patients with pulmonary arterial hypertension.

Rain S, Handoko ML, Trip P, Gan CT, Westerhof N, Stienen GJ, Paulus WJ, Ottenheijm CA, Marcus JT, Dorfmüller P, Guignabert C, Humbert M, Macdonald P, Dos Remedios C, Postmus PE, Saripalli C, Hidalgo CG, Granzier HL, Vonk-Noordegraaf A, van der Velden J, de Man FS.

Circulation. 2013 Oct 29;128(18):2016-25, 1-10. doi: 10.1161/CIRCULATIONAHA.113.001873. Epub 2013 Sep 20.

PMID:
24056688
30.

Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.

Surie S, Reesink HJ, Marcus JT, van der Plas MN, Kloek JJ, Vonk-Noordegraaf A, Bresser P.

Clin Cardiol. 2013 Nov;36(11):698-703. doi: 10.1002/clc.22197. Epub 2013 Aug 27.

31.

Effects of diaphragm plication on pulmonary function and cardiopulmonary exercise parameters.

Welvaart WN, Jak PM, van de Veerdonk MC, Marcus JT, Ottenheijm CA, Paul MA, Vonk Noordegraaf A.

Eur J Cardiothorac Surg. 2013 Oct;44(4):643-7. doi: 10.1093/ejcts/ezt094. Epub 2013 Feb 28.

PMID:
23449864
32.

Accurate assessment of load-independent right ventricular systolic function in patients with pulmonary hypertension.

Trip P, Kind T, van de Veerdonk MC, Marcus JT, de Man FS, Westerhof N, Vonk-Noordegraaf A.

J Heart Lung Transplant. 2013 Jan;32(1):50-5. doi: 10.1016/j.healun.2012.09.022. Epub 2012 Nov 17.

PMID:
23164535
33.

Aortic function quantified: the heart's essential cushion.

Saouti N, Marcus JT, Vonk Noordegraaf A, Westerhof N.

J Appl Physiol (1985). 2012 Oct 15;113(8):1285-91. doi: 10.1152/japplphysiol.00432.2012. Epub 2012 Aug 30.

34.

Early-diastolic left ventricular lengthening implies pulmonary hypertension-induced right ventricular decompensation.

Lumens J, Arts T, Marcus JT, Vonk-Noordegraaf A, Delhaas T.

Cardiovasc Res. 2012 Nov 1;96(2):286-95. doi: 10.1093/cvr/cvs251. Epub 2012 Aug 8.

PMID:
22875469
35.

Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress.

Mauritz GJ, Vonk-Noordegraaf A, Kind T, Surie S, Kloek JJ, Bresser P, Saouti N, Bosboom J, Westerhof N, Marcus JT.

J Cardiovasc Magn Reson. 2012 Jan 12;14:5. doi: 10.1186/1532-429X-14-5.

36.

Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, Bogaard HJ, Boonstra A, Marques KM, Westerhof N, Vonk-Noordegraaf A.

J Am Coll Cardiol. 2011 Dec 6;58(24):2511-9. doi: 10.1016/j.jacc.2011.06.068.

37.

Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension.

Wong YY, Westerhof N, Ruiter G, Lubberink M, Raijmakers P, Knaapen P, Marcus JT, Boonstra A, Lammertsma AA, van der Laarse WJ, Vonk-Noordegraaf A.

Eur J Heart Fail. 2011 Dec;13(12):1290-5. doi: 10.1093/eurjhf/hfr140. Epub 2011 Oct 20. Erratum in: Eur J Heart Fail. 2012 Oct;14(10):1190.

38.

Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension.

Mauritz GJ, Kind T, Marcus JT, Bogaard HJ, van de Veerdonk M, Postmus PE, Boonstra A, Westerhof N, Vonk-Noordegraaf A.

Chest. 2012 Apr;141(4):935-943. doi: 10.1378/chest.10-3277. Epub 2011 Sep 29.

PMID:
21960697
39.

Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization.

Wong YY, Ruiter G, Lubberink M, Raijmakers PG, Knaapen P, Marcus JT, Boonstra A, Lammertsma AA, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A.

Circ Heart Fail. 2011 Nov;4(6):700-6. doi: 10.1161/CIRCHEARTFAILURE.111.962381. Epub 2011 Sep 7.

PMID:
21900188
40.

Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension.

Wong YY, Raijmakers PG, Knaapen P, Lubberink M, Ruiter G, Marcus JT, Boonstra A, Lammertsma AA, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A.

Heart. 2011 Dec;97(24):2069-74. doi: 10.1136/heartjnl-2011-300237. Epub 2011 Aug 31.

PMID:
21880654
41.

Longitudinal and transverse movements of the right ventricle: both are important in pulmonary arterial hypertension.

Kind T, Marcus JT, Westerhof N, Vonk-Noordegraaf A.

Chest. 2011 Aug;140(2):556-557. doi: 10.1378/chest.10-3195. No abstract available.

PMID:
21813538
42.

Early onset of retrograde flow in the main pulmonary artery is a characteristic of pulmonary arterial hypertension.

Helderman F, Mauritz GJ, Andringa KE, Vonk-Noordegraaf A, Marcus JT.

J Magn Reson Imaging. 2011 Jun;33(6):1362-8. doi: 10.1002/jmri.22581.

PMID:
21591004
43.

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness.

Rüssel IK, Brouwer WP, Germans T, Knaapen P, Marcus JT, van der Velden J, Götte MJ, van Rossum AC.

J Cardiovasc Magn Reson. 2011 Jan 10;13:3. doi: 10.1186/1532-429X-13-3.

44.

Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI.

de Langen AJ, van den Boogaart V, Lubberink M, Backes WH, Marcus JT, van Tinteren H, Pruim J, Brans B, Leffers P, Dingemans AM, Smit EF, Groen HJ, Hoekstra OS.

J Nucl Med. 2011 Jan;52(1):48-55. doi: 10.2967/jnumed.110.078261. Epub 2010 Dec 13.

45.

Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction.

Mauritz GJ, Marcus JT, Westerhof N, Postmus PE, Vonk-Noordegraaf A.

Heart. 2011 Mar;97(6):473-8. doi: 10.1136/hrt.2010.193375. Epub 2010 Oct 7.

PMID:
20930045
46.

Clinically significant change in stroke volume in pulmonary hypertension.

van Wolferen SA, van de Veerdonk MC, Mauritz GJ, Jacobs W, Marcus JT, Marques KMJ, Bronzwaer JGF, Heymans MW, Boonstra A, Postmus PE, Westerhof N, Vonk Noordegraaf A.

Chest. 2011 May;139(5):1003-1009. doi: 10.1378/chest.10-1066. Epub 2010 Sep 23.

PMID:
20864614
47.

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging.

Dingemans AM, de Langen AJ, van den Boogaart V, Marcus JT, Backes WH, Scholtens HT, van Tinteren H, Hoekstra OS, Pruim J, Brans B, Thunnissen FB, Smit EF, Groen HJ.

Ann Oncol. 2011 Mar;22(3):559-66. doi: 10.1093/annonc/mdq391. Epub 2010 Aug 11.

48.

Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure.

Saouti N, Westerhof N, Helderman F, Marcus JT, Boonstra A, Postmus PE, Vonk-Noordegraaf A.

Am J Respir Crit Care Med. 2010 Nov 15;182(10):1315-20. doi: 10.1164/rccm.200910-1643OC. Epub 2010 Jul 9.

PMID:
20622041
49.

Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension.

Kind T, Mauritz GJ, Marcus JT, van de Veerdonk M, Westerhof N, Vonk-Noordegraaf A.

J Cardiovasc Magn Reson. 2010 Jun 4;12:35. doi: 10.1186/1532-429X-12-35.

50.

Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure.

Boerrigter B, Mauritz GJ, Marcus JT, Helderman F, Postmus PE, Westerhof N, Vonk-Noordegraaf A.

Chest. 2010 Dec;138(6):1395-401. doi: 10.1378/chest.10-0363. Epub 2010 May 21.

PMID:
20495109

Supplemental Content

Loading ...
Support Center